Skip to main content

Table 3 Differences in Epstein Barr virus (EBV) antibody levels among controls, by risk factors for classical Kaposi sarcoma

From: Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30

 

mean difference*

(95% CI)

Cofactor

EBNA-1

VCA

Age, continuous

0.00 (-0.02 to 0.02)

0.02 (0.00 to 0.04)

Sex

  

Male

Female

-1.21 (-1.78 to -0.64)

Reference

-2.14 (-2.67 to -1.62)

Reference

Smoking status

  

Never

Former

Current

-0.62 (-1.30 to 0.07)

-0.82 (-1.41 to -0.23)

Reference

-2.37 (-3.01 to -1.73)

-1.09 (-1.64 to -0.54)

Reference

Diabetes

  

Yes

No

-0.82 (-1.29 to -0.34)

Reference

-0.84 (-1.29 to -0.40)

Reference

Cortisone use in last 10 years

  

Yes

No

-0.41 (-0.89 to 0.06)

Reference

-0.46 (-0.89 to -0.02)

Reference

KSHV antibody status

  

Positive

Negative

0.18 (-0.22 to 0.59)

Reference

0.11 (-0.27 to 0.49)

Reference

  1. * Mean difference from multivariate linear regression models that included all variables shown.